Why the study?
To summarize currently available therapeutic strategies for preventing VT recurrences in ICM, their optimal timing, and future perspectives following recent trials.
Population
Patients with ischaemic cardiomyopathy and ventricular tachycardia
Design
Review
Authors
Loading...
Adjunctive ablation may curb VT recurrences in ICM; leaves open survival benefit and need for targeted RCTs.
Catheter ablation reduces VT recurrence in patients with ischemic cardiomyopathy and is particularly recommended for recurrent VT after ICD therapy, alongside optimized ICD programming.
Kahle et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: